KINTOR PHARMA-B 09939Hong Kong Stock Exchange

1.6350.91%( -0.015 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
KINTOR PHARMA-B (09939) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-05-22
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG5273B1077

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)38.33M101/112
Net Profit (Last FY)-234.66M80/125
ROE (Last FY)-109.59%111/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
开拓药业有限公司 Executive Director
KINTOR PHARMACEUTICAL LIMITED Executive Director
童友之 Executive Director
倪翔 Executive Director
陈云飞 Non-Executive Director
卫舸琪 Non-Executive Director
徐敏 Independent Non-Executive Director
杨怀严 Independent Non-Executive Director
童亮 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-12-11.

About this page

This page shows KINTOR PHARMA-B (09939) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.